Introduction
Cryptococcus neoformans is an encapsulated, basidiomycetous yeast that is present in the environment worldwide. It has been isolated from a large variety of natural substrates, especially soil contaminated with pigeon droppings (Khan et al., 1978; Li et al., 1993; Lopez-Martinez & CastanonOlivares, 1995) , decaying wood in tree trunk hollows (Lazera et al., 2000; Randhawa et al., 2003) and fruit and vegetables (Pal & Mehrotra, 1985; Lopez-Martinez & Castanon-Olivares, 1995) . The main portal of entry is the respiratory tract, and lungs are the primary site of infection. In most instances, the infection is subclinical and self-limiting. However, the infection may be reactivated during immunosuppression of the host, particularly under the conditions of depressed Tcell-mediated immunity. The most important predisposing condition is AIDS (Pema et al., 1994; Mitchell & Perfect, 1995) , but the disease can also occur in individuals receiving immunosuppressive therapy, such as patients with cancer, sarcoidosis, Hodgkin's lymphoma or those who have undergone organ transplantation (Mitchell & Perfect, 1995) . Following haematogenous dissemination from the lungs, the central nervous system (CNS) and skin are the preferred sites of infection in about 6-15 % of patients (Powderly, 1993; Christianson et al., 2003) . Primary cutaneous cryptococcosis (PCC) has also been reported in immunocompetent as well as immunocompromised individuals (Revenga et al., 2002; Neuville et al., 2003; Christianson et al., 2003) .
Cryptococcosis from the Middle East has been sporadically reported (Abdel-Fattah et al., 1975; Al-Rasheed & Al-Fawaz, 1990; Sa'adah et al., 1995; Nampoory et al., 1996; Khan et al., 2003; Abdel-Salem, 2003) . Of the three cases of cryptococcosis in renal transplant recipients from Kuwait reported previously, one had cutaneous lesions with CNS involvement, but chest X-rays were normal (Nampoory et al., 1996) . In this communication, we describe a case of cutaneous cryptococcosis in a renal transplant recipient manifesting as cellulitis, which was the only sign of the disease when diagnosis was made.
Case report
A 60-year-old Kuwaiti male underwent live-unrelated renal transplant in April 1988. Earlier, he had adult dominant polycystic kidney disease (ADPKD), which required pretransplant bilateral nephrectomy. His post-transplant course was uncomplicated. He was maintained on triple immunosuppression comprising prednisolone, azathioprine and cyclosporine A with normal graft function. His serum creatinine levels were maintained between 110 and 120 ìmol l À1 . In 1992, he developed mild hypertension and diabetes mellitus that was adequately controlled by a calcium channel blocker and sulphonylurea derivatives. In May 2000, he developed a chest infection with bilateral pulmonary infiltrates caused by Haemophilus influenzae that was reAbbreviations: BAL, bronchoalveolar lavage; PCC, primary cutaneous cryptococcosis.
solved completely by macrolides. Two years later, in February 2002, he presented with fever and features of cellulitis involving the calf region of the left leg (Fig. 1a) . The examination revealed a tender, indurated, erythematous lesion, about 20 cm in diameter, with bullae formation. Clinically, he did not look toxic, and there was no evidence of lymphadenopathy or abdominal organomegaly. His lungs were clear and he showed no neurological deficit including meningeal signs. His total white blood cell count ranged between 6 and 8 3 10 9 l À1 , platelet count was 160 3 10 9 l
À1
and haemoglobin was 10 . 6 g dl À1 . Blood coagulation profile, liver and renal function tests were within normal limits.
The summary of laboratory investigations is presented in Table 1 . Since urine and blood cultures did not reveal any pathogen, he was empirically treated with parenteral thirdgeneration cephalosporin, cloxacillin and clindamycin on the assumption that his cellulitis was probably of bacterial origin. However, no clinical improvement was observed with this therapeutic regimen. Subsequently, the infected area was debrided and the swab, tissue and aspirate were sent for microbiological examination. Direct microscopic examination of the aspirated material, swab smears and tissue showed poorly capsulated budding yeast cells and yielded C. neoformans in culture. The identity of the isolate was confirmed with the Vitek 2 yeast identification system, by the ability to produce brown colonies on niger seed agar at 28 8C, and by a mouse pathogenicity test which showed the formation of large capsulated yeast cells when examined 5 days postintracerebral inoculation. His serum was positive for cryptococcal antigen (titre 1 : 4) by latex agglutination kit (Pastorex Crypto Plus; Bio-Rad). He was immediately given liposomal amphotericin B (AmBisome) at a dose of 3 mg kg À1 day À1 . The isolate was susceptible to amphotericin B (0 . 016 ìg ml À1 ) and fluconazole (2 . 0 ìg ml À1 ) but resistant to flucytosine (. 16 ìg ml À1 ) by E-test on RPMI agar (NCCLS, 1997). A week later, he developed bilateral chest infiltrates with drowsiness. A CT scan of his brain and cerebrospinal fluid (CSF) were normal. India ink examination of CSF was negative for C. neoformans and the pathogen did not grow in culture. The latex agglutination test for cryptococcal polysaccharides in CSF was also negative. However, his bronchoalveolar lavage (BAL) grew Pseudomonas aeruginosa. He was treated with meropenem, which resulted in complete resolution of the chest infiltrates. Since the patient responded to AmBisome, he continued to receive the drug for 21 days (total dose 4 . 8 g), followed by oral fluconazole (Diflucan) 200 mg daily for 4 months and then 100 mg daily for another 4 months. The patient's cellulitic lesion gradually resolved completely (Fig. 1b) . When examined for the last time on 18 June 2003, he was afebrile and his renal and liver function parameters were within the normal range. He is being maintained on minimal triple immunosuppression regimen.
Discussion
Cutaneous cryptococcosis in most immunocompromised patients is a sign of disseminated disease (Thomas & Schwartz, 2001) . However, critical analysis of the literature in two recent reviews (Neuville et al., 2003; Christianson et al., 2003) suggests that cutaneous cryptococcosis can also occur as a primary disease both in immunocompetent and immunocompromised individuals, where skin serves as the primary portal of entry. This observation is noteworthy since the existence of PCC as a distinct clinical entity has been controversial, despite some well-documented case reports (Goonetilleke et al., 1995; Hamann et al., 1997; Handa et al., 1998) . C. neoformans has been shown to cause almost every type of cutaneous lesion. The lesions may occur as ulcers (Birkett & McMurray, 1976) , pustules (Crounse & Lerner, 1958) , granulomata (Crounse & Lerner, 1958; Rook & Woods, 1962) , abscesses (Rook & Woods, 1962 ) and herpetiform or molluscum contagiosum-like lesions (Borton & Wintroub, 1984; Concus et al., 1988; Pema et al., 1994) . Although a rarity, several cases of cellulitis have also been reported (Anderson et al., 1992; Gloster et al., 1994; Horrevorts et al., 1994) , which appear to be mainly restricted to lower parts of the body, especially the legs (Horrevorts et al., 1994) , as was seen in the present case. Based on the analysis of 28 cases of PCC, Neuville et al. (2003) proposed criteria for diagnosing this entity. According to these criteria, cutaneous lesions in secondary/disseminated disease are usually multiple and scattered, located both in clothed and exposed areas, whereas skin lesions characterizing PCC are solitary or confined to a limited area and located on unclothed areas. On the other hand, Christianson et al. (2003) reviewed 73 cases of PCC and drew a distinction in location of lesions between non-immunocompromised and immunocompromised individuals. Involvement of finger and facial sites was more commonly seen in nonimmunocompromised hosts, whereas multiple sites of infection or infection localized to extremities of the lower body or to the trunk were seen more frequently in the immunocompromised patients.
Despite the asymptomatic nature of pulmonary cryptococcosis in most cases, symptoms are non-specific when manifested, and hence are not helpful in clinical diagnosis. Fever, dyspnoea, cough, chest pain or haemoptysis may be observed in about 18-54 % of patients (Campbell, 1996; Diamond, 1990) . Since the organism has a preference to invade the CNS, meningitis or meningoencephalitis is often the first clinical evidence of infection. In severely immunocompromised patients, such as those with AIDS, meningeal signs may be subdued and inflammatory response in the CSF reduced, which may result in diagnostic delays. However, our patient had no pulmonary or meningeal signs or symptoms at the time of diagnosis of cutaneous cryptococcosis and culture of BAL and CSF were negative on repeated occasions (Table 1) . Other preferred sites of C. neoformans infection include the urinary tract (prostate), bone and the skin. Some 20-30 % of transplant recipients may develop skin lesions weeks to months prior to development of CNS manifestations (Rubin, 1988) . Our patient appears to fall into this category, since he had no CNS manifestations or positive CSF findings at the time of diagnosis, although he had a low cryptococcal antigen titre (1 : 4) in serum, which may be attributed either to an early stage of the disease or to the weakly capsulated nature of the strain, or both.
The dermatotropic characteristic of C. neoformans may vary depending upon the strain or serotype involved (Mitchell & Perfect, 1995; Dromer et al., 1996) . Although our patient was infected with serotype A, it has been reported that serotype D has a greater propensity to cause skin lesions (Naka et al., 1995; Dromer et al., 1996) . Besides dermatotropism, differences in temperature tolerance and geographical distribution between serotypes could be other factors (Chen et al., 2000; Martinez et al., 2001) . In renal transplant recipients, infection due to C. neoformans occurs almost exclusively in the late post-transplant phase, from 4 months after transplantation and onwards. The incidence of the infection appears to vary between 0 . 8 and 5 . 8 % depending upon the type and intensity of immunosuppression used (Gallis et al., 1975 , Nampoory et al., 1996 Husain et al., 2001 ). Our patient was Cryptococcal cellulitis on triple immunosuppression including prednisolone, and also had diabetes mellitus. Usage of corticosteroids has been found to be the most common risk factor in an analysis of 37 patients with PCC (Christianson et al., 2003) . Recently, increased risk of dermatological presentation and decreased risk of CNS infection has been noted with the use of tacrolimus in solid organ transplant recipients (Husain et al., 2001) . Cyclosporine A and tacrolimus have been shown to suppress the growth of C. neoformans in vitro by inhibiting the calcineurin pathway at 37 8C but not at 24 8C (Cruz et al., 2000) . However, cyclosporine A fails to cross the bloodbrain barrier effectively, while tacrolimus achieves a good CNS concentration. Thus, temperature-dependent inhibition of cryptococci by tacrolimus may prevent CNS infection, but allow the growth of the fungus at cooler body sites, such as the skin.
Regardless of the primary or secondary nature of cutaneous cryptococcosis, the most sensitive and specific approach for its diagnosis is microscopic examination and culture of a skin biopsy specimen or material aspirated from the skin lesion. Direct microscopic examination of the material in potassium hydroxide or India ink can reveal encapsulated yeast cells. Additional diagnostic evidence should be obtained to rule out systemic dissemination. This may include culture of sputum, BAL, CSF and urine (preferably after prostatic massage), as well as serological evidence for cryptococcal polysaccharide in serum and/or CSF specimens. Culture for C. neoformans should be positive in 3-7 days, colonies appearing as white to cream coloured with a mucoid consistency, but growth is inhibited by the presence of cycloheximide in the medium (Diamond, 1990) . Being a basidiomycetous yeast, it is urease-positive. In addition, this yeast produces phenoloxidase, an enzyme that is associated with melanin synthesis, which turns the colour of the colonies brown on a medium containing a specific Dopalike substrate, such as the one provided by niger seed medium. Capsular polysaccharide, urease and phenoloxidase are known virulence factors of C. neoformans and thus play an important role in the pathogenesis of the disease (Casadevall & Perfect, 1998) .
Considering the asymptomatic nature of pulmonary cryptococcosis in the majority of cases, and the demonstration of a low antigen titre (1 : 4) in our patient, it may be inferred that he was probably in the early phase of a disseminated disease where the cutaneous lesion appeared as the first clinical manifestation. This observation is consistent with the prevailing view that all cases of cutaneous cryptococcosis in immunocompromised patients should be assumed to be due to disseminated infection until proved otherwise (Casadevall & Perfect, 1998) . Such patients need aggressive antifungal chemotherapy. Our patient was given AmBisome for 3 weeks, followed by fluconazole. He responded to this therapy adequately, resulting in resolution of cellulitis and clearance of the cryptococcal antigen from the serum. Since the isolate was resistant to flucytosine and the patient had no meningeal involvement, this drug was not included in the treatment regimen. Primary resistance to flucytosine in clinical isolates of C. neoformans has been reported previously (CuencaEstrella et al., 2001; Kantarcioglu & Yucel, 2002) .
